As states take important steps to lower prescription drug costs, at least six have implemented prescription drug affordability review initiatives, although approaches vary across states. The National Academy for State Health Policy (NASHP)’s new chart, Comparison of State Prescription Drug Affordability Review Initiatives, provides a road map of the diverse efforts taken by Maryland, Maine, […]
Author Archive for: trish-riley
About Trish Riley
Trish Riley is executive director of the National Academy for State Health Policy (NASHP) and president of its corporate board. She helped build NASHP as CEO from 1988 to 2003.
Previously, she was a senior fellow in State Health Policy at George Washington University and at the Muskie School of Public Service, University of Southern Maine. From 2003 to 2011, she served as director of the Maine Governor’s Office of Health Policy and Finance, leading Maine’s effort to develop a comprehensive, coordinated state health system that included increasing access to affordable health insurance. She was the principal architect of Dirigo Health Reform and served as Maine’s liaison to the federal government and Congress, particularly during deliberations around national health reform. She chaired the Governor’s Steering Committee to develop a plan to implement the Affordable Care Act in Maine.
Riley has also held appointed positions under five Maine governors, directing the Office on Aging, Medicaid and state health agencies, and health planning and licensing programs.
Riley has published and presented widely about state health reform. She served as a member of the Kaiser Commission on Medicaid and the Uninsured, the Medicaid and CHIP Payment and Access Commission (MACPAC), the Health Services Committee of the Institute of Medicine, the National Academy for Social Insurance, and the board of directors of Maine’s co-op insurance plan. She was a member of the Institute of Medicine’s Subcommittee on Creating an External Environment for Quality. She also previously served as a member of the board of directors of the National Committee on Quality Assurance. Riley holds a BS and MS from the University of Maine.
Entries by Trish Riley
Burdened by high US drug prices that average 218 percent more than in Canada, innovative states across the country are exploring a range of approaches to give their residents the same access to affordable drugs Canadians have. To date, six leading states have passed laws that enable them to import drugs from Canada pending federal […]
In its understandable urgency to build a long-needed national strategy on COVID-19, the Biden Administration faces a patchwork of state-based initiatives that can simultaneously support and confound a new national strategy. The previous Administration made states the frontlines against COVID-19 and, working with the US Centers for Disease Control and Prevention (CDC), states have built […]
In my first job, almost a half century ago, I had the privilege of leading Maine’s successful effort to abolish mandatory retirement – my first experience with a state breaking ground – well before federal action to do the same. I fought hard to ensure that no one had to leave a job because of […]
During this pandemic holiday season, when it’s an act of love to stay distant, it can be hard to find things to celebrate. But vaccines are on their way and state leaders have done the unimaginable to build systems to educate, track, trace, treat, and now vaccinate millions of Americans. That is worth celebrating. Last […]
Last week, states won a clear path to regulating pharmacy benefit managers (PBMs) in a unanimous US Supreme Court ruling in Rutledge vs. Pharmaceutical Care Management Association (PCMA). At issue was whether federal law preempted an Arkansas law (Act 900) that requires PBMs to reimburse pharmacies at no less than what pharmacies pay to acquire […]
I am very pleased to announce the inaugural class of NASHP’s Emerging Leaders of Color Fellowship as a small step to achieve our goals of racial equity in state health policy. We were humbled to receive 108 applications for the three available fellowships and moved by the testimony of each fellow as they shared their […]
As COVID-19 infections, hospitalizations and deaths soar and federal guidance evolves, states are finetuning their vaccine distribution plans as the US Food and Drug Administration (FDA) appears poised to approve a vaccine later this week. The timely, safe, and equitable distribution of the vaccines falls squarely on states and their providers, who are already stretched […]
As expected, last week the Pharmaceutical Research and Manufacturers of America (PhRMA) filed suit in US District Court for the District of Columbia to block a new federal rule that allows states to import less costly prescription drugs from Canada. Also last week, the Canadian Minister of Health issued an order prohibiting the bulk export […]
As he launched his Covid-19 Task Force this week, President-elect Joe Biden moved quickly to turn his health care campaign promises into policies in preparation for entering the Oval Office in January. In addition to ending the pandemic, Biden plans to build on the Affordable Care Act (ACA) by expanding access to and affordability of […]